Furthermore, TTBK1 is known to act on neuropathic proteins like tau at pathogenically relevant sites and is overexpressed in Alzheimer’s disease (AD) with single nucleotide polymorphisms associated with late-onset AD (Ikezu and Ikezu, 2014; Bashore et al., 2023). Here, MAPT is linked to Alzheimer disease.